News and Trends 26 Mar 2020 Novacyt Launches Two-Hour Coronavirus Test After FDA Approval The French clinical diagnostics specialist Novacyt has announced FDA authorization for its fast and easily transportable test for the coronavirus disease COVID-19. The company is also rolling out the kit this week via manufacturing and distribution partnerships across Europe. The test received an Emergency Use Authorization from the FDA, which means it can only be […] March 26, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 25 Mar 2020 DBV Technologies’ Peanut Allergy Treatment Hits FDA Setback French biotech DBV Technologies’ bid for the US approval of a skin patch to treat nut allergies could be delayed as the FDA requested more information on the patch’s efficacy. Specifically, the FDA requested more information on patch-site adhesion – critical to the patch working effectively – as well as its long-term efficacy. According to […] March 25, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2020 Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s disease drug has increased in worth by €38M with a new milestone payment. AC Immune and Eli Lilly modified a deal signed in late 2018 to co-develop a small molecule treatment to slow the progression of Alzheimer’s disease. Specifically, the […] March 24, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2020 Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II The UK immunotherapy company Vaccitech has announced promising initial results from a phase IIa trial of a therapeutic vaccine that could offer a new way to treat advanced prostate cancer. In the open-label trial, the University of Oxford spin-off enrolled 23 patients with advanced castration-resistant prostate cancer. The patients received the company’s viral vector vaccine […] March 24, 2020 - 2 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 23 Mar 2020 ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for the treatment of HIV in Canada, which could replace the need for daily antiretroviral pills. The treatment — branded as Cabenuva and developed in collaboration with Janssen — was approved by Health Canada to suppress HIV in adults with stable […] March 23, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 23 Mar 2020 Riding the Wave of Cambridge Entrepreneurship The University of Cambridge is world-famous, but unlike its US equivalent, the city isn’t as well known for its startup culture. Jason Mellad, CEO of StartCodon — a new accelerator based there — believes the area is a great place to set up a new biotech. “When I arrived in 2004, there were several people, […] March 23, 2020 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 20 Mar 2020 Themis and Institut Pasteur Join Coronavirus Vaccine Hunt The Austrian biotech Themis — specializing in vaccines for infectious and insect-borne diseases — has jumped on the coronavirus vaccine bandwagon along with the Institut Pasteur and other international partners. The collaboration will be led by the Parisian Institut Pasteur, whose vaccine technology — in this case modifying a measles virus vector to carry coronavirus […] March 20, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 19 Mar 2020 Labiotech.eu’s Coverage of the Covid-19 Coronavirus Like many others, the biopharma industry has been shaken by the rapid rise of the coronavirus outbreak. But unlike any other industry, biopharma can solve the growing threat through science and innovation. Our journalists are working hard to deliver as much information as possible on the current crisis. If quality information and independent journalism also […] March 19, 2020 - 13 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 18 Mar 2020 OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments Austrian startup OncoOne has closed its first round of venture capital funding after raising €13M to investigate a new treatment target against solid tumor cancers. Investment in the Series A funding included public grants from the Austrian Research Promotion Agency and the promotional bank of the Austrian federal government, the Austria Wirtschaftsservice Gesellschaft, along with […] March 18, 2020 - 2 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 17 Mar 2020 CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute The German biotech CureVac — which is developing an mRNA vaccine against coronavirus — has been granted up to €80M by the European Commission, shortly after a dispute erupted over an alleged acquisition offer from the US. The money was awarded to help CureVac quickly scale up the production of its candidate Covid-19 vaccine. It […] March 17, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 16 Mar 2020 Coronavirus Delays Sensorion’s Hearing Loss Phase II Trial The French company Sensorion has been forced to delay a phase II trial in people with hearing loss due to slow patient recruitment amid the current coronavirus disease (Covid-19) pandemic. The clinical trial is designed to test Sensorion’s lead candidate drug in people with sudden sensorineural hearing loss, a rare disorder where the patient can […] March 16, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Mar 2020 Immune Marker in Blood May Predict Kidney Transplant Rejection Risk French researchers have found that the levels of certain immune cells in the blood of kidney transplant recipients may predict their future risk for transplant rejection. At present, kidney transplantation is the best treatment for people with end-stage renal disease but introducing a ‘foreign’ organ into someone’s body comes with the risk of rejection by […] March 13, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email